- Home
- A-Z Publications
- Current Drug Discovery Technologies
- Previous Issues
- Volume 12, Issue 4, 2015
Current Drug Discovery Technologies - Volume 12, Issue 4, 2015
Volume 12, Issue 4, 2015
-
-
Using NMR to Develop New Allosteric and Allo-Network Drugs
Authors: Robert E. Smith, Kevin Tran, Kristy M. Richards and Rensheng LuoNMR is becoming an important tool for developing new allosteric and allo-network drugs that bind to allosteric sites on enzymes, partially inhibiting them and causing fewer side effects than drugs already developed that target active sites. This is based on systems thinking, in which active enzymes and other proteins are known to be flexible and interact with each other. In other words, proteins can exist in an ensemble of d Read More
-
-
-
Sortase A Mediated Protein Modifications and Peptide Conjugations
Authors: Natalya Voloshchuk, Danni Liang and Jun F. LiangBioactive peptides regulate many physiological processes, acting at some sites as endocrine or paracrine signals and at others as neurotransmitters or growth factors, and show useful properties for human health, including antimicrobial, antifungal, antiviral, and antitumor activities. Although most peptides can be produced using the molecular biology approach, they are produced in limited quantities at hig Read More
-
-
-
NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer’s Disease
Alzheimer’s disease (AD) is supposed to stanch from inappropriate waving in the brain sections related to memory and perception. The incidence of AD in distressed person associated with an upsurge in the accumulation of amyloid plaque-rich senile plaques and neurofibrillary tangles in the brain. We hypothesize that a combination therapy provides a new treatment for AD. We propose that an anti-AD drug, NGA, a combinati Read More
-
-
-
From in vitro Experiments to in vivo and Clinical Studies; Pros and Cons
Authors: Soodabeh Saeidnia, Azadeh Manayi and Mohammad AbdollahiBiomedical investigators use different methods including experimental animals, tissue, and cell cultures as well as computational simulations and clinical studies finding the ways to treat human diseases and disorders. All the mentioned procedures have their own advantages and disadvantages. For instance although animal models provide some drawbacks like difference in biokinetics parameters or extrapolation Read More
-
-
-
Antimalarial Drug: From its Development to Deface
More LessWiping out malaria is now the global concern as about three billion people are at risk of malaria infection globally. Despite of extensive research in the field of vaccine development for malaria, till now, no effective vaccine is available for use and hence only antimalarial drugs remain our best hope for both treatment and prevention of malaria. However, emergence and spread of drug resistance has been a major obstacle for t Read More
-
-
-
Green Propolis: Thirteen Constituents of Polar Extract and Total Flavonoids Evaluated During Six Years through RP-HPLC
In order to verify the chemical qualities of polar extract of Green Propolis produced in the State of Minas Gerais, Brazil, was analyzed by means of RP-HPLC, the concentration of eleven flavonoids, Artepillin C and p-coumaric acid were analyzed by means of RP-HPLC. Samples were collected in the months of February, March, May, July, September, and October, during a period of six years (2008 to 2013) and the results compare Read More
-
-
-
Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line
Authors: Seyed H. Hejazi, Ghasem Ahangari and Abdolkhaegh DeezagiBackground: Neurotransmitters had progressive effects on various cancers via their different type of receptors. Objective: This study was conducted to determine the pattern of serotonin receptors, respectively, 5HTR2A and 5HTR3A gene expression in MCF-7 cells and evaluate their selective antagonist effects on them. Method: RT-PCR was performed to determine the pattern of serotonin receptor gene expression in Read More
-
Volumes & issues
-
Volume 22 (2025)
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/cddt
Journal
10
5
false
en
